
Many
factors contribute to female sexual function, which changes with age and in the
years surrounding menopause. Female sexual dysfunction is prevalent and
associated with distressing symptoms that can challenge relationships and
hamper quality of life and wellbeing. The most common type of female
sexual dysfunction is lowered sexual desire. Contributing factors to female
sexual dysfunction are highlighted, with a focus on those relevant to peri- and
postmenopausal women. Assessment and management of women with female sexual
dysfunction is discussed, including the role of menopausal hormone therapy,
testosterone and other targeted treatments. New and emerging treatments
are outlined.
RACGP QI&CPD Program 2020-22 Triennium,
Activity ID: 152985 Total Points 1 Category 2
ACRRM: Activity 20064 1 PDP
Access to this course is $10 (GST INC) by payment through PayPal.
Note: You do not require a PayPal account as the process accepts major credit cards.
AMS Members are pre-enrolled.